Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 OCT 20 ... ability of different imaging investigations, including CT, MRI, endoscopic ultrasound, octreotide scintigraphy and arterial stimulation with simultaneous venous sampling (ASVS), to ...
2009 NOV 9 ... to recent research published in the journal Surgery Today, "To determine the effect of octreotide, octreotide with zinc, levamisole, and misoprostol on ...
2009 SEP 28 ... and early total enteral nutrition were routinely adopted. Grade III patients received octreotide during hospitalization and for 6 months after discharge. Eleven patients (2 with grade I ...
2009 OCT 27 ... New research, 'Influence of tumour size and uptake of 99mTc-octreotide on radio-guided surgery for neuroendocrine tumors,' is the subject of a report. "The ...
2009 OCT 12 ... tumors (NET) of the midgut who were treated with Sandostatin=AE LAR Depot (octreotide acetate for injectable suspension) experienced a 66% reduction in risk of disease ...
2009 NOV 16 ... Q-Leuprolide (primary indications in prostate cancer and endometriosis) and Q-Octreotide (primary indications in acromegaly, and palliative care). Q-Leuprolide and Q...
2009 OCT 5 ... The researchers concluded: "We report a patient in whom long term (60 months) octreotide-L.A.R administration resulted in complete disappearance of a growth hormone secreting ...
2009 NOV 16 ... fistula, was not alleviated with opioid and topical treatment. Three days after starting octreotide 0.3 mg/d, the severe pain was alleviated, and follow-up retrograde urography revealed ...
2009 NOV 16 ... included 45 de novo patients (18 women and 27 men, aged 20-82 yr); 28 were treated with octreotide-long-acting release and 17 with lanreotide. GH was controlled in 100% and IGF-I levels ...
2009 OCT 19 ... in random order. On each visit, overnight endogenous GH production was suppressed by octreotide. Three 1-h pulses of recombinant human GH (rhGH) or placebo were administered on two ...
2009 SEP 28 ... drainage systems by MAC lymphadenitis. Even with intensive antimycobacterial treatment, octreotide treatment as a long-acting somatostatin analogue, and a low-fat diet enriched with ...
2009 SEP 28 ... or blockade of the somatostatin (SRIF) receptor 2 (sst(2)) with two SRIF analogues, octreotide and D-Tyr(8) cyanamid 154806 (CYN), influences retinal vascularization and levels of ...
2009 OCT 6 ... "The seroma was successfully dealt with daily drainages and with administration of octreotide and etilefrine." Vassilikos and colleagues published their study in ...
2009 NOV 9 ... in 1 patient. Two patients with hepatic metastases received a combination therapy of octreotide, surgery, and chemotherapy, which resulted in symptom improvement and normalization of ...
2009 NOV 23 ... research from Lanzhou, People's Republic of China, "To evaluate the effectiveness of octreotide in advanced hepatocellular carcinoma participants on the basis of randomized controlled ...
2009 NOV 9 ... in patients with well-differentiated metastatic midgut NETs. The hypothesis was that octreotide LAR prolongs time to tumor progression and survival. Treatment-naive patients were ...
2009 OCT 19 ... a metastatic pancreatic insulinoma and severe hypoglycemia. A continuous infusion of octreotide lowered the blood glucose levels further. He required diazoxide, a thiazide diuretic, ...
2009 OCT 19 ... (gamma >5). The findings are based on observed C-E relationships for two drugs, octreotide and remifentanil, characterized by simple E (max) and sigmoid E (max) models ...
2009 NOV 9 ... that target and bind to neuroendocrine cancer cells. (90)Yttrium-DOTA-Phe1-Tyr3-octreotide and radioactive drugs which targets cells by binding to somatostatin receptors. ...
